Attractive drug candidate identified to target glioma brain tumors

Researchers have identified a biomarker enzyme associated with aggressive glioma brain tumors, and have revealed the regulatory mechanism for that enzyme. In a new study, they demonstrate potent efficacy, using a mouse model of glioma, for a small molecule inhibitor they have developed.